|
Peter Argenta, MD
 argenta@umn.edu
612-626-6037, administrative office Dr. Argenta's Clinical Profile
(University of Minnesota Physicians Web site) Dr. Argenta is an Associate Professor in the Department of Obstetrics, Gynecology and Women’s Health, Division of Gynecologic Oncology. In addition, Dr. Argenta is the Medical Director of the Park Nicollet Oncology Clinic. Dr. Argenta received his medical degree in 1995 from Duke University and completed an internship and residency in obstetrics and gynecology at the University of Pennsylvania. He completed a fellowship in gynecologic oncology at Mount Sinai School of Medicine. Dr. Argenta is board certified in obstetrics and gynecology as well as the subspecialty of gynecologic oncology. Dr. Argenta’s research interests lie in the areas of early events in carcinogenesis and the molecular mechanisms of wound healing, the treatment and prevention of ovarian cancer, with specific interest in using antiangiogenic agents in the management of metastatic tumors. In addition, Dr. Argenta has acquired specialty training in the Intuitive Surgical® daVinci® Surgical System. Selected Publications Bradley WH, Boente MP, Brooker D, Argenta PA, Downs LS, Judson PL, Carson LF. Hysteroscopy and cytology in endometrial cancer. Obstet Gynecol. 2004;104(5 pt 1):1030-3. Downs LS Jr, Judson PL, Argenta PA, Carson LF, Boente MP. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer. Gynecol Oncol. 2004;95(2):347-51. Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol. 2004;95(3):632-6. Argenta PA, Kubicek GJ, Dusenbery KE, Judson PL, Downs LS, Carson LF, Boente MP. Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancer. Gynecol Oncol. 2005;97(2):659-61. Dusenbery KE, Potish RA, Argenta PA, Judson PL. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus. Am J Clin Oncol. 2005;28(3):295-300. Argenta PA, Ghebre R, Dusenbery KE, Chen MD, Judson PL, Downs LS Jr, Carson LF. Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: Long-term follow-up. Eur J Gynaecol Oncol. 2006;27(3):231-5. Skubitz AP, Pambuccian SE, Argenta PA, Skubitz KM. Differential gene expression identifies subgroups of ovarian carcinoma. Transl Res. 2006;148(5):223-48. Chura JC, Shukla K, Argenta PA. Brain metastasis from cervical carcinoma. Int J Gynecol Cancer. 2007;17(1):141-6. Korell AN, Argenta PA, Strathy JH. Prolonged obstructed labor causing a severe obstetric fistula: A case report. J Reprod Med. 2007;52(6):555-6. Goudge CS, Downs LS, Judson PL, Argenta PA. Stage II squamous cell carcinoma of the vagina in a patient with Bloom syndrome: A case report. J Reprod Med. 2007;52(6):557-9. Leath CA 3rd, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA, Argenta PA, Gold MA. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol. 2007;105(3):630-4. Chura JC, Boyd A, Argenta PA. Surgical site infections and supplemental perioperative oxygen in colorectal surgery patients: A systematic review. Surg Infect. 2007;8(4):455-62. Chura JC, Marushin R, Boyd A, Ghebre R, Geller MA, Argenta PA. Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: A retrospective analysis and literature review. Gynecol Oncol. 2007;107(1):79-85. Argenta PA, Thomas S, Chura JC. Proximal-type epithelioid sarcoma vs. malignant rhabdoid tumor of the vulva: A case report, review of the literature, and an argument for consolidation. Gynecol Oncol. 2007;107(1):130-5. Downs LS Jr, Judson PL, Argenta PA, Ghebre R, Geller MA, Bliss RL, Boente MP, Nahhas WA, Abu-Ghazaleh SZ, Chen MD, Carson LF. A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma. Cancer 2008;112(2):331-9. Argenta PA, Ormsby RR, Downs LS, Judson PL, Ghebre R, Carson LF. Routine pelvic examination during front-line chemotherapy for ovarian cancer: should it play a role? J Reprod Med. 2008 Jan; 53(1):3-7. Chura JC, Ryu HS, Simard M, Poirier D, Tremblay Y, Brooker DC, Blomquist CH, Argenta PA. Steroid-converting enzymes in human ovarian carcinomas. Mol Cell endocrinol. 2009 Mar 25; 301(1-2):51-8. Epub 2008 Aug 3. Chura JC, Blomquist CH, Ryu HS, Argenta PA. Estrone sulfatase activity in patients with advanced ovarian cancer. Gynecol Oncol. 2009 Jan; 112(1): 205-9. Epub 2008 Oct 22. Geller MA, Argenta PA, Thomas SG, Dusenbery KE, Judson PL, Boente MP. Feasibility and morbidity of using saline filled tissue expanders to reduce radiation-induced bowel injury in patients with gynecologic malignancies. Eur J Obstet Gynecol Reprod Biol. 2009 Apr; 143(2): 93-7. Epub 2009 Feb 4. Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, De Geest K, Mutch DG, Burger RA, Swart AM, Trimble EL, Accario-Winslow C, Roth LM. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: A phase III trial of the Gynecologic Cancer InterGroup. J Clin Oncol. 2009 Feb 17. [Epub ahead of print]. Argenta PA, Thomas SG, Judson PL, Downs LS Jr, Geller MA, Carson LF, Jonson AL, Ghebre R. A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer. Gynecol Oncol. 2009 Feb 22 [Epub ahead of print]. Lanneau GS, Argenta PA, Lanneau MS, Riffenburgh RH, Gold MA, McMeekin DS, Webster N, Judson PL. Vulvar cancer in young women: demographic features and outcome evaluation. Am J Obstet Gynecol. 2009 Mar 13. [Epub ahead of print]. Clinics:
|
